Neuropeptide Analogues for Selective Insect Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for greener, target-specific insecticides that minimize harm to non-target species like pollinators while effectively controlling pest insects, as broad-spectrum insecticides have detrimental environmental impacts.

Innovation Solution

Development of natural or natural-like analogues of insect pyrokinin and AKH neuropeptides, and their combinations, which exhibit insecticidal activity against specific insect pests like hemipteran, dipteran, lepidopteran, blattodean, and coleopteran insects, while having minimal effect on important pollinators such as bees.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If broad-spectrum insecticides are used, then pest control effectiveness is improved, but environmental harm and damage to non-target species increases

Engineering Contradiction:
Improvepest control effectivenessVSAvoidenvironmental harm
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by designing neuropeptide analogues with specific sequence modifications (e.g., N-terminal extensions, C-terminal modifications) that confer selectivity to target insect species. These localized structural changes enable the peptide to interact specifically with receptors in pest insects while minimizing effects on non-target species like bees and pollinators, thus achieving effective pest control with reduced environmental harm.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent employs parameter changes by systematically varying amino acid sequences, molecular weight, charge distribution, and structural conformation of neuropeptide analogues. These parameter modifications optimize binding affinity to target insect receptors while reducing off-target effects, enabling selective pest control that maintains effectiveness against pests while minimizing environmental impact.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If modified synthetic neuropeptides are developed, then target-specific insecticidal activity is improved, but regulatory approval difficulty increases

Engineering Contradiction:
Improvetarget-specific insecticidal activityVSAvoidregulatory approval complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent utilizes naturally occurring amino acids and biodegradable peptide structures that break down into harmless byproducts in the environment. This approach simplifies regulatory approval by demonstrating inherent environmental safety and biocompatibility, avoiding the need for complex long-term toxicity studies required for synthetic chemicals, thus reducing regulatory complexity while maintaining target-specific activity.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Object-affected harmful factors

If neuropeptide analogues are designed for selectivity, then harm to non-target species is reduced, but insecticidal activity against target pests may be compromised

Engineering Contradiction:
Improveharm to non-target speciesVSAvoidinsecticidal activity
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent applies segmentation by dividing the neuropeptide structure into distinct functional domains: an N-terminal region for receptor binding specificity, a central core for structural stability, and a C-terminal region for activity modulation. This segmentation allows independent optimization of each region to achieve both high target specificity and potent insecticidal activity, ensuring that selectivity does not compromise effectiveness.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentEP4544911B1Insect neuropeptides
Publication Date: 2025.11.19 SOLASTA BIO LTD
  • EP4544911B1 patent drawingFigure 1
  • EP4544911B1 patent drawingFigure 2
  • EP4544911B1 patent drawingFigure 3

AI summary

The present invention relates to natural or natural-like analogues of insect pyrokinin neuropeptides and AKH neuropeptides, and combinations thereof, having activity against insects, for example hemipteran, dipteran, lepidopteran, blattodean and/or coleopteran insects, such as aphids, moths and fruit flies, and their use as insect control agents (e.g. insecticides) and plant protection agents.